colon cancer News
Most Popular colon cancer Story
Roche dealt setback as Avastin misses trial goal
Roche's stock dropped 10 percent in Swiss trading following the announcement that Avastin did not meet the primary endpoint in a highly-anticipated Phase III trial. The trial tested whether Avastin Read more...
Latest Headlines
- April 22, 2009
- May 16, 2008
- October 3, 2007
- September 14, 2007
- January 25, 2007
- January 9, 2007
- October 11, 2006
- August 31, 2006
- June 20, 2006
- February 12, 2006
- November 8, 2005
- October 5, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
